Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
H.S. junior Avg
|
|
New words:
alter, animal, assumption, BRC, chain, chattel, commodity, complaint, compliant, COVID, CPCH, CPD, CVS, deeper, deforestation, developoed, discern, disinfect, Dismissal, dismissing, driven, drying, EBITDA, endeavor, exacerbate, export, facial, footprint, Forbearance, formatted, gave, greenhouse, Hexo, incredibly, infection, Interactive, Mike, nearest, nil, nourishing, NPA, ourproprietary, persist, policymaking, priority, protracted, quantitative, quarantine, receipt, recession, resurgence, Revolution, Rob, roll, Stack, stewardship, surfactant, suspected, technique, tort, vaccination, vaccine, waste, welfare, Wuhan, xi
Removed:
accredited, affirmatively, approximation, Assignor, attribution, bar, cease, collaborate, computing, consecutive, constructive, Cooperate, Correspondingly, decision, disclosing, feasibility, fifty, Gould, Hundred, investee, irrevocably, marked, media, monetization, oak, opt, package, parent, participate, priced, print, reclassification, reclassified, resigned, restatement, revised, SPA, supplement, syndrome, Targeted, Territory, thousand, title
Filing tables
Filing exhibits
AVRW similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Forms S-8 (No. 333-222565, 333-227791 and 333-250978) and Form S-3 (No. 333-251039) of Cure Pharmaceutical Holding Corp., (the “Company”) of our report dated April 1, 2022, with respect to the Company’s consolidated financial statements as of December 31, 2021 and 2020, which appears in this annual report on Form 10-K for the year ended December 31, 2021.
RBSM, LLP
Las Vegas, NV
April 1, 2022